Moderna Validates mRNA Cancer Strategy With Phase 3 Melanoma Data

By Adam Feuerstein · STAT News · 2026-10-26

Moderna Validates mRNA Cancer Strategy With Phase 3 Melanoma Data

STAT News reports that Moderna CEO Stéphane Bancel is shifting focus toward expanding the company's oncology pipeline following successful Phase 3 results for its melanoma therapy, intismeran. Developed alongside Merck, the customized mRNA treatment represents a milestone for a t

STAT News reports that Moderna CEO Stéphane Bancel is shifting focus toward expanding the company's oncology pipeline following successful Phase 3 results for its melanoma therapy, intismeran. Developed alongside Merck, the customized mRNA treatment represents a milestone for a t